Latest News about David Pidduck
Recent news which mentions David Pidduck
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
November 14, 2024
From Benzinga
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
August 14, 2024
From Benzinga
From Benzinga
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
March 27, 2024
From Benzinga
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
February 07, 2024
From Benzinga
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
November 14, 2023
From Benzinga
From Benzinga
MediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDA
May 15, 2023
From Benzinga
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
April 13, 2023
From Benzinga
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
March 31, 2023
From Benzinga
MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details
August 15, 2022
Tickers
MEDIF
From Benzinga
MediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility
July 11, 2022
Tickers
MEDIF
From Benzinga